Literature DB >> 24991905

Cognitive and language outcomes in HIV-uninfected infants exposed to combined antiretroviral therapy in utero and through extended breast-feeding.

Mary S Ngoma1, Jennifer A Hunter, Jessica A Harper, Paige T Church, Scholastica Mumba, Mulapati Chandwe, Hélène C F Côté, Arianne Y K Albert, Mary-Lou Smith, Chisomo Selemani, Paul A Sandstrom, Lucas Bandenduck, Utsile Ndlovu, Sara Khan, Lina Roa, Michael S Silverman.   

Abstract

OBJECTIVE: To determine whether there is a higher risk for cognitive or language delay among HIV-exposed uninfected (HEU) children exposed to cART (zidovudine/lamivudine/lopinavir/ritonavir) in utero and through 1 year of breast-feeding (World health Organization Option B+), compared with the control children born to HIV-uninfected mothers.
DESIGN: This is a double cohort study from Lusaka, Zambia.
METHODS: HEU (n = 97) and control (n = 103) children aged 15-36 months were assessed on their early nonverbal problem-solving and language skills using the standardized Capute Scales. A score of less than 85 on the Capute Full-Scale Developmental Quotient (FSDQ) was considered indicative of developmental delay and was the primary outcome of interest.
RESULTS: An FSDQ of less than 85 was found in eight (8.3%) of HEU participants and 15 (14.6%) of controls. In univariate logistic regressions, lower income [odds ratio (OR) = 0.93, P = 0.02], older infant age (OR = 1.08, P = 0.03), lower birth weight (OR = 0.16, P < 0.001), and less maternal education (OR = 0.41, P = 0.047) were associated with the probability of FSDQ less than 85, whereas Group (control/HEU) was not (OR = 1.88, P = 0.16). In the multivariable analysis, only lower birth weight (OR = 0.15, P < 0.001) remained associated with FSDQ less than 85.
CONCLUSIONS: Our study did not support the presence of an adverse effect on cognitive and language development with prolonged antepartum and postpartum cART e/xposure. Larger studies and studies of older HEU children will be required to confirm these reassuring findings.

Entities:  

Mesh:

Year:  2014        PMID: 24991905     DOI: 10.1097/QAD.0000000000000357

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  13 in total

1.  Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial.

Authors:  Linda Barlow-Mosha; Konstantia Angelidou; Jane Lindsey; Moherndran Archary; Mark Cotton; Sylvia Dittmer; Lee Fairlie; Enid Kabugho; Portia Kamthunzi; Arti Kinikar; Tapiwa Mbengeranwa; Levina Msuya; Pauline Sambo; Kunjal Patel; Emily Barr; Patrick Jean-Phillipe; Avy Violari; Lynne Mofenson; Paul Palumbo; Benjamin H Chi
Journal:  Clin Infect Dis       Date:  2016-07-20       Impact factor: 9.079

2.  Neurodevelopment of breastfed HIV-exposed uninfected and HIV-unexposed children in South Africa.

Authors:  Stanzi M le Roux; Kirsten A Donald; Kirsty Brittain; Tamsin K Phillips; Allison Zerbe; Kelly K Nguyen; Andrea Strandvik; Max Kroon; Elaine J Abrams; Landon Myer
Journal:  AIDS       Date:  2018-08-24       Impact factor: 4.177

Review 3.  Contemporary Issues in Pregnancy (and Offspring) in the Current HIV Era.

Authors:  Allison Ross Eckard; Stephanie E Kirk; Nancy L Hagood
Journal:  Curr HIV/AIDS Rep       Date:  2019-12       Impact factor: 5.071

4.  Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero.

Authors:  Abhinav Ajaykumar; Mayanne Zhu; Fatima Kakkar; Jason Brophy; Ari Bitnun; Ariane Alimenti; Hugo Soudeyns; Sara Saberi; Arianne Y K Albert; Deborah M Money; Hélène C F Côté
Journal:  J Infect Dis       Date:  2021-02-24       Impact factor: 5.226

5.  Cognitive and physical development in HIV-positive children in South Africa and Malawi: A community-based follow-up comparison study.

Authors:  L Sherr; I S Hensels; M Tomlinson; S Skeen; A Macedo
Journal:  Child Care Health Dev       Date:  2017-10-19       Impact factor: 2.508

6.  Paediatric HIV: Progress on Prevention, Treatment and Cure.

Authors:  Maria H Kim; Saeed Ahmed; Elaine J Abrams
Journal:  Curr Pediatr Rep       Date:  2015-07-22

7.  In utero and peripartum antiretroviral exposure as predictor of cognition in 6- to 10-year-old HIV-exposed Ugandan children - a prospective cohort study.

Authors:  A E Ezeamama; S K Zalwango; A Sikorskii; R Tuke; P M Musoke; B Giordani; M J Boivin
Journal:  HIV Med       Date:  2021-04-16       Impact factor: 3.180

8.  Growth and health outcomes at school age in HIV-exposed, uninfected Zambian children: follow-up of two cohorts studied in infancy.

Authors:  Laura Nicholson; Molly Chisenga; Joshua Siame; Lackson Kasonka; Suzanne Filteau
Journal:  BMC Pediatr       Date:  2015-06-06       Impact factor: 2.125

Review 9.  Antiretroviral Treatment in HIV-1-Positive Mothers: Neurological Implications in Virus-Free Children.

Authors:  Antonio Victor Campos Coelho; Paola Maura Tricarico; Fulvio Celsi; Sergio Crovella
Journal:  Int J Mol Sci       Date:  2017-02-15       Impact factor: 5.923

10.  Perinatal HIV Infection or Exposure Is Associated With Low N-Acetylaspartate and Glutamate in Basal Ganglia at Age 9 but Not 7 Years.

Authors:  Frances C Robertson; Martha J Holmes; Mark F Cotton; Els Dobbels; Francesca Little; Barbara Laughton; André J W van der Kouwe; Ernesta M Meintjes
Journal:  Front Hum Neurosci       Date:  2018-05-07       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.